Breaking News, Financial News

Financial Report: WuXi PharmaTech

Manufacturing revenues up 23% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech
 
3Q Revenues: $173.6 million (+18%)

3Q Earnings: $32.0 million (+5%)

YTD Revenues: $483.6 million (+15%)

YTD Earnings: $79.2 million (-3%)

Comments: Lab services revenue grew 17% in the quarter to $126.0 million, with China-based revenue up 18% to $100.5 million and U.S.-based revenue up 11% to $25.5 million. Manufacturing revenues were $47.6 million, up 23%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters